Showing results (1-10 of 1,996) with videos related to

Sort By:
Pageof 200
American Journal of Cancer Research|March 23, 2026
Dyskerin dysfunction in cancer development: from telomere dysregulation to immune deficiencyYihang Xie, Ningning Xue, Lin Xue, et al.
BMC Oral Health|September 16, 2024
The first description of mucous membrane pemphigoid induced by enalapril maleate: a case reportYihang Xie, Qiyue Zhang, Lin Ye, et al.
BMC Oral Health|October 14, 2023
Identification of the causal relationship between sleep quality, insomnia, and oral ulcersQianxi Liu, Jiongke Wang, Tiannan Liu, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|July 9, 2021
Coexistence of oral mucous membrane pemphigoid and lichenoid drug reaction: a case of toripalimab-triggered and pembrolizumab-aggravated oral adverse eventsShumin Duan, Xuefeng Zhang, Fei Wang, et al.
Photodiagnosis and Photodynamic Therapy|May 25, 2022
Photodynamic therapy for extensive oral verrucous/granular leukoplakia with moderate-to-severe dysplasia: A case studyQiyue Zhang, Fei Wang, Jing Liang, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 23, 2025
Trends in immunotherapy for oral squamous cell carcinomaNingning Xue, Ying Wang, Ziyuan Wang, et al.
Orphanet Journal of Rare Diseases|April 21, 2025
Extensive and persistent tongue ulceration is an early character of dyskeratosis congenitaXuefeng Zhang, Hongxia Dan, Yu Zhou, et al.
International Journal of Oncology|January 4, 2022
[Corrigendum] Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathwayXuefeng Zhang, Na Liu, Danhua Ma, et al.
International Journal of Oncology|June 10, 2016
Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathwayXuefeng Zhang, Na Liu, Danhua Ma, et al.
Ultrasonics|July 15, 2025
Optimal design and experimental study on a novel relaxor ferroelectric single crystal transducer based on face shear vibration modeSanrui Wu, Yihang Xie, Fushi Bai, et al.
Pageof 200